Literature DB >> 27049667

Chronic Hyperinsulinemia Increases Myoblast Proliferation in Fetal Sheep Skeletal Muscle.

Laura D Brown1, Stephanie R Wesolowski1, Jenai Kailey1, Stephanie Bourque1, Averi Wilson1, Sasha E Andrews1, William W Hay1, Paul J Rozance1.   

Abstract

Insulin is an important fetal growth factor. However, chronic experimental hyperinsulinemia in the fetus fails to accelerate linear and lean mass growth beyond normal rates. Mechanisms preventing accelerated lean mass accretion during hyperinsulinemia are unknown. To address potential mechanisms, late-gestation fetal sheep were infused with iv insulin and glucose to produce euglycemic hyperinsulinemia (INS) or saline for 7-9 days. Fetal substrate uptake and protein metabolic rates were measured. INS fetuses had 1.5-fold higher insulin concentrations (P < .0001) and equivalent glucose concentrations. INS fetuses had 20% more Pax7(+) nuclei in the biceps femoris, which indicates the potential for hyperinsulinemia to increase the number of myoblasts within late-gestation fetal skeletal muscle. Additionally, the percentage of Pax7(+) myoblasts that expressed Ki-67 was 1.3-fold higher and expression of myogenic regulatory factors was 50% lower in INS fetuses (MYF5 and MYOG [myogenin], P < .005), which indicates a shift toward myoblast proliferation over differentiation. There were no differences for fetal body, organ, or muscle weights, although INS placentas weighed 28% less (P < .05). Protein synthesis and accretion rates did not change in INS fetuses, nor did fiber muscle size. Essential amino acid concentrations were lower in the INS group (P < .05) except for tryptophan. Umbilical blood flow, net total amino acids, and O2 uptakes rates did not differ between groups. Arterial O2 content was 33% lower (P < .005) and norepinephrine was 100% higher in the INS fetuses (P < .01), all of which are factors that may counteract fetal protein accretion during hyperinsulinemia despite an increase in myoblast proliferation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27049667      PMCID: PMC4891788          DOI: 10.1210/en.2015-1744

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  53 in total

1.  O(2) regulates skeletal muscle progenitor differentiation through phosphatidylinositol 3-kinase/AKT signaling.

Authors:  Amar J Majmundar; Nicolas Skuli; Rickson C Mesquita; Meeri N Kim; Arjun G Yodh; Michelle Nguyen-McCarty; M Celeste Simon
Journal:  Mol Cell Biol       Date:  2011-10-17       Impact factor: 4.272

Review 2.  Fiber types in mammalian skeletal muscles.

Authors:  Stefano Schiaffino; Carlo Reggiani
Journal:  Physiol Rev       Date:  2011-10       Impact factor: 37.312

3.  Hyperinsulinemia and macrosomia.

Authors:  R Schwartz
Journal:  N Engl J Med       Date:  1990-08-02       Impact factor: 91.245

4.  Regulation of bovine satellite cell proliferation and differentiation by insulin and triiodothyronine.

Authors:  I Cassar-Malek; N Langlois; B Picard; Y Geay
Journal:  Domest Anim Endocrinol       Date:  1999-11       Impact factor: 2.290

5.  Effects of insulin on ovine fetal leucine kinetics and protein metabolism.

Authors:  J R Milley
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

6.  Diagnosis and treatment of gestational diabetes according to amniotic fluid insulin levels.

Authors:  P A Weiss; H M Hofmann; R R Winter; W Lichtenegger; P Pürstner; J Haas
Journal:  Arch Gynecol       Date:  1986

7.  Increased amino acid supply potentiates glucose-stimulated insulin secretion but does not increase β-cell mass in fetal sheep.

Authors:  Monika M Gadhia; Anne M Maliszewski; Meghan C O'Meara; Stephanie R Thorn; Jinny R Lavezzi; Sean W Limesand; William W Hay; Laura D Brown; Paul J Rozance
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-12-04       Impact factor: 4.310

8.  Changes in protein metabolism of ovine primary muscle cultures on treatment with growth hormone, insulin, insulin-like growth factor I or epidermal growth factor.

Authors:  J M Harper; J B Soar; P J Buttery
Journal:  J Endocrinol       Date:  1987-01       Impact factor: 4.286

Review 9.  Endocrine regulation of fetal skeletal muscle growth: impact on future metabolic health.

Authors:  Laura D Brown
Journal:  J Endocrinol       Date:  2014-04-22       Impact factor: 4.286

Review 10.  Epigenetic and developmental influences on the risk of obesity, diabetes, and metabolic syndrome.

Authors:  Caitlin J Smith; Kelli K Ryckman
Journal:  Diabetes Metab Syndr Obes       Date:  2015-06-29       Impact factor: 3.168

View more
  11 in total

Review 1.  ASAS-SSR Triennnial Reproduction Symposium: Looking Back and Moving Forward-How Reproductive Physiology has Evolved: Fetal origins of impaired muscle growth and metabolic dysfunction: Lessons from the heat-stressed pregnant ewe.

Authors:  Dustin T Yates; Jessica L Petersen; Ty B Schmidt; Caitlin N Cadaret; Taylor L Barnes; Robert J Posont; Kristin A Beede
Journal:  J Anim Sci       Date:  2018-06-29       Impact factor: 3.159

Review 2.  Risk of hypertension following perinatal adversity: IUGR and prematurity.

Authors:  Trassanee Chatmethakul; Robert D Roghair
Journal:  J Endocrinol       Date:  2019-07-01       Impact factor: 4.286

3.  Myoblast replication is reduced in the IUGR fetus despite maintained proliferative capacity in vitro.

Authors:  Susan M Soto; Amy C Blake; Stephanie R Wesolowski; Paul J Rozance; Kristen B Barthel; Bifeng Gao; Byron Hetrick; Carrie E McCurdy; Natalia G Garza; William W Hay; Leslie A Leinwand; Jacob E Friedman; Laura D Brown
Journal:  J Endocrinol       Date:  2017-01-04       Impact factor: 4.286

4.  Lower citrate synthase activity, mitochondrial complex expression, and fewer oxidative myofibers characterize skeletal muscle from growth-restricted fetal sheep.

Authors:  Jane Stremming; Eileen I Chang; Leslie A Knaub; Michael L Armstrong; Peter R Baker; Stephanie R Wesolowski; Nichole Reisdorph; Jane E B Reusch; Laura D Brown
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-12-15       Impact factor: 3.619

5.  Intermittent maternofetal oxygenation during late gestation improved birthweight, neonatal growth, body symmetry, and muscle metabolism in intrauterine growth-restricted lambs.

Authors:  Caitlin N Cadaret; Robert J Posont; Rebecca M Swanson; Joslyn K Beard; Rachel L Gibbs; Taylor L Barnes; Eileen S Marks-Nelson; Jessica L Petersen; Dustin T Yates
Journal:  J Anim Sci       Date:  2022-01-01       Impact factor: 3.159

6.  Primary myoblasts from intrauterine growth-restricted fetal sheep exhibit intrinsic dysfunction of proliferation and differentiation that coincides with enrichment of inflammatory cytokine signaling pathways.

Authors:  Robert J Posont; Micah S Most; Caitlin N Cadaret; Eileen S Marks-Nelson; Kristin A Beede; Sean W Limesand; Ty B Schmidt; Jessica L Petersen; Dustin T Yates
Journal:  J Anim Sci       Date:  2022-08-01       Impact factor: 3.338

7.  Effects of chronic hyperinsulinemia on metabolic pathways and insulin signaling in the fetal liver.

Authors:  Paul J Rozance; Amanda K Jones; Stephanie L Bourque; Angelo D'Alessandro; William W Hay; Laura D Brown; Stephanie R Wesolowski
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-08-24       Impact factor: 4.310

8.  Rates of myogenesis and myofiber numbers are reduced in late gestation IUGR fetal sheep.

Authors:  Eileen I Chang; Paul J Rozance; Stephanie R Wesolowski; Leanna M Nguyen; Steven C Shaw; Robert A Sclafani; Kristen K Bjorkman; Angela K Peter; William Hay; Laura D Brown
Journal:  J Endocrinol       Date:  2019-12-19       Impact factor: 4.286

9.  Late gestation fetal hyperglucagonaemia impairs placental function and results in diminished fetal protein accretion and decreased fetal growth.

Authors:  Sarah N Cilvik; Stephanie R Wesolowski; Russ V Anthony; Laura D Brown; Paul J Rozance
Journal:  J Physiol       Date:  2021-05-10       Impact factor: 6.228

10.  Dual effects of obesity on satellite cells and muscle regeneration.

Authors:  Ashley E Geiger; Morgan R Daughtry; Con-Ning Yen; Laila T Kirkpatrick; Hao Shi; David E Gerrard
Journal:  Physiol Rep       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.